CompletedPhase 3

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

NCT01777282

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Aichi, Japan

+48 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2013-02-23
Enrollment: 374 participants
Sponsor: GlaxoSmithKline
Purpose: treatment

Locations (49)

GSK Investigational SiteAichi, Japan
GSK Investigational SiteChiba, Japan
GSK Investigational SiteEhime, Japan
GSK Investigational SiteFukuoka, Japan
GSK Investigational SiteFukuoka, Japan
GSK Investigational SiteFukuoka, Japan
GSK Investigational SiteFukushima, Japan
GSK Investigational SiteFukushima, Japan
GSK Investigational SiteGunma, Japan
GSK Investigational SiteGunma, Japan
GSK Investigational SiteHokkaido, Japan
GSK Investigational SiteHokkaido, Japan
GSK Investigational SiteIbaraki, Japan
GSK Investigational SiteIbaraki, Japan
GSK Investigational SiteKagawa, Japan
GSK Investigational SiteKagoshima, Japan
GSK Investigational SiteKanagawa, Japan
GSK Investigational SiteKanagawa, Japan
GSK Investigational SiteKanagawa, Japan
GSK Investigational SiteKanagawa, Japan
GSK Investigational SiteKochi, Japan
GSK Investigational SiteKumamoto, Japan
GSK Investigational SiteKumamoto, Japan
GSK Investigational SiteKyoto, Japan
GSK Investigational SiteKyoto, Japan
GSK Investigational SiteKyoto, Japan
GSK Investigational SiteMiyagi, Japan
GSK Investigational SiteMiyagi, Japan
GSK Investigational SiteNagano, Japan
GSK Investigational SiteNagano, Japan
GSK Investigational SiteOkinawa, Japan
GSK Investigational SiteOsaka, Japan
GSK Investigational SiteOsaka, Japan
GSK Investigational SiteOsaka, Japan
GSK Investigational SiteOsaka, Japan
GSK Investigational SiteOsaka, Japan
GSK Investigational SiteŌita, Japan
GSK Investigational SiteSaitama, Japan
GSK Investigational SiteSaitama, Japan
GSK Investigational SiteSaitama, Japan
GSK Investigational SiteSaitama, Japan
GSK Investigational SiteSaitama, Japan
GSK Investigational SiteSaitama, Japan
GSK Investigational SiteShizuoka, Japan
GSK Investigational SiteTochigi, Japan
GSK Investigational SiteTokyo, Japan
GSK Investigational SiteTokyo, Japan
GSK Investigational SiteTokyo, Japan
GSK Investigational SiteTokyo, Japan